Drug safety evaluation of defibrotide Review uri icon

Overview

MeSH Major

  • Hematopoietic Stem Cell Transplantation
  • Hepatic Veno-Occlusive Disease
  • Polydeoxyribonucleotides

abstract

  • DF was well tolerated in majority of the studies. The safety profile of DF is largely favourable with toxicities comparable to control populations in the setting of SCT complicated by sVOD.

publication date

  • January 2013

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1517/14740338.2012.749855

PubMed ID

  • 23228043

Additional Document Info

start page

  • 123

end page

  • 36

volume

  • 12

number

  • 1